Azmet-VG 2mg/500mg/0.2mg Tablet SR
Marketer
Azkka Pharmaceuticals Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.2mg)
Overview Azmet-VG 2mg/500mg/0.2mg Tablet SR
Diabeva-Trio 2mg/500mg/0.2mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, assisting in the regulation of blood glucose. Diabeva-Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continuous use is crucial; discontinuation without medical consultation can elevate blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are paramount in diabetes control. Hypoglycemia (low blood sugar) is a frequent adverse effect; familiarize yourself with its symptoms (sweating, dizziness, headache, tremors) and appropriate management strategies. Regular meals and readily available glucose sources (e.g., sugary snacks, juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Additional side effects may include altered taste, nausea, diarrhea, abdominal discomfort, headache, edema, blurred vision, fractures, and upper respiratory infections. Weight gain is a possibility. Contraindications include type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or lactating individuals require medical consultation prior to use. Regular blood glucose monitoring, along with periodic blood tests for complete blood count and liver function, are recommended.
Primary Ingredients of Azmet-VG 2mg/500mg/0.2mg Tablet SR
No text provided to rephrase.
Uses of Azmet-VG 2mg/500mg/0.2mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Azmet-VG 2mg/500mg/0.2mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume the Azmet-VG 2mg/500mg/0.2mg Extended-Release tablet on an empty stomach.
Common Side effects of Azmet-VG 2mg/500mg/0.2mg Tablet SR:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Azmet-VG 2mg/500mg/0.2mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Azmet-VG 2mg/500mg/0.2mg Extended-Release Tablet on an empty stomach.
How Azmet-VG 2mg/500mg/0.2mg Tablet SR works:
Azmet-VG SR tablets (2mg/500mg/0.2mg) contain a triple-action formulation for diabetes management.
SAFETY ADVICE
AlcoholUNSAFE
Combining Azmet-VG 2mg/500mg/0.2mg SR tablets with alcohol is strongly discouraged due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Azmet-VG 2mg/500mg/0.2mg SR tablets during pregnancy might pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Azmet-VG tablets (2mg/500mg/0.2mg) are likely unsafe for breastfeeding mothers. Available data from humans indicate potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.
KidneyUNSAFE
The use of Azmet-VG 2mg/500mg/0.2mg SR tablets is likely unsafe for individuals with kidney impairment and should be prevented. Patients with severe kidney disease should especially avoid this medication. Medical advice is necessary.
LiverCAUTION
Individuals with liver impairment should use Azmet-VG 2mg/500mg/0.2mg SR tablets cautiously. Dosage modification may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Azmet-VG 2mg/500mg/0.2mg SR tablets are typically initiated at a low dose; however, their use is contraindicated in patients with severe liver dysfunction.
What if you forget to take Azmet-VG 2mg/500mg/0.2mg Tablet SR :
Should you forget to take your Azmet-VG 2mg/500mg/0.2mg Tablet SR, ingest it immediately upon remembering. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Azmet-VG 2mg/500mg/0.2mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently